Serviços Personalizados
Journal
Artigo
Espanhol (pdf)
Artigo em XML
Referências do artigo
Tradução automática
Enviar este artigo por emailIndicadores
Citado por SciELO 
Acessos
Links relacionados
Citado por Google 
Similares em
SciELO 
Similares em Google
Compartilhar
Permalink
Revista Colombiana de Nefrología
versão On-line ISSN 2500-5006
Resumo
CHACON ACEVEDO, Kelly et al. Efficacy and safety of chloroquine, hydroxychloroquine and azithromycin in patients with COVID-19: Summary of evidence. Rev. colom. nefrol. [online]. 2020, vol.7, suppl.2, pp.21-41. Epub 08-Maio-2021. ISSN 2500-5006. https://doi.org/10.22265/acnef.7.supl.2.469.
Introduction:
The COVID-19 disease is a health emergency; treatment has not yet been proven.
Objective:
To present the available evidence of efficacy and safety of the use of hydroxychloroquine and azithromycin in the prophylaxis and management of patients with COVID-19.
Methods:
A rapid literature review was performed; we consulted Medline, scopus and pubmed databases.
Results:
Eleven publications were included including rapid literature reviews, observational studies, and clinical trials. No data were found studying prophylaxis with hydroxychloroquine and azithromycin for SARS-CoV-2. Reports of adverse events include episodes of emesis, abdominal pain, nausea, diarrhea, rash, and itching.
Conclusions:
The evidence collected suggests that the use of hydroxychloroquine and azithromycin in patients with COVID-19, could abnormal electrocardiogram and increased risk of mortality in-hospital. The effectiveness remains unclear.
Palavras-chave : COVID-19; hydroxychloroquine; azithromycin; adverse drug event; prophylaxis (MeSH).
